title: [Clinical Significance of Placing a PEG during Chemoradiotherapy for Advanced Esophageal Cancer].
abstract: BACKGROUND
  Unresectable advanced esophageal cancer is often treated with chemotherapy or chemoradiotherapy(CRT). Nutritional disorders caused by dysphagia may lead to a poor prognosis. Placing a PEG before starting CRT for advanced esophageal cancer may maintain better nutritional status.
  
  
  OBJECTIVE
  The purpose of this study is to evaluate the clinical significance of placing a PEG before starting CRT for advanced esophageal cancer.
  
  
  RESULTS
  Fifty-one cases were evaluated, 22 PEG (+) and 29 PEG (-). The rate of a CRT was better in PEG (+) than PEG (-) cases (91% vs 79%). Infection around the PEG was the only type of complication, affecting 5%.
  
  
  CONCLUSIONS
  PEG feeding during CRT is important in the development of effective treatments for unresectable advanced esophageal cancer.
authors.affiliation: Dept. of Surgery, Yao Municipal Hospital.
authors.forename: Jin
authors.initials: J
authors.lastname: Matsuyama
authors.forename: Yoko
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Yamato
authors.forename: Mitsunobu
authors.initials: M
authors.lastname: Takeda
authors.forename: Yasuji
authors.initials: Y
authors.lastname: Hashimoto
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Shirakawa
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Tokuoka
authors.forename: Yoshihito
authors.initials: Y
authors.lastname: Ide
authors.forename: Shigekazu
authors.initials: S
authors.lastname: Yokoyama
authors.forename: Yukio
authors.initials: Y
authors.lastname: Fukushima
authors.forename: Ken
authors.initials: K
authors.lastname: Kodama
authors.forename: Yo
authors.initials: Y
authors.lastname: Sasaki
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000628:therapy*; D059248:Chemoradiotherapy / Q000009:adverse effects; D003680:Deglutition Disorders / Q000209:etiology; D004750:Enteral Nutrition; D004938:Esophageal Neoplasms / Q000150:complications / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome